Supporting the Primary Outcomes of the Mirai Trial for the Adjunctive Digital Therapeutic Rejoyn (CT-152) in the Treatment of Major Depressive Disorder: Meaningful Change Analysis in the Montgomery-Åsberg Depression Rating Scale.
JMIR formative research · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AdultFemaleHumansMaleMiddle AgedAntidepressive AgentsDigital HealthMajor Depressive DisorderPsychiatric Status Rating ScalesPsychometricsTreatment Outcomecognitive therapydigital health interventionmeaningful within-patient changepatient-reported outcomespsychopharmacological augmentation therapy
Come citare questo studio
Stacie Hudgens, Intan Purnajo, Lysbeth Floden, Steve Hwang, Jessica Ash, Brian Rothman, Austin Speier, Ainslie Forbes. (2026). Supporting the Primary Outcomes of the Mirai Trial for the Adjunctive Digital Therapeutic Rejoyn (CT-152) in the Treatment of Major Depressive Disorder: Meaningful Change Analysis in the Montgomery-Åsberg Depression Rating Scale.. JMIR formative research. DOI: 10.2196/85037
Consulta la pubblicazione originale ↗